Does contrast agent injection during trans-catheter aortic valve implantation negatively affect kidney function?

Kardiologia Polska

Volumn 69, Issue 3, 2011, Pages 251-255

  Podolecka, Ewa ^a   Chmielak, Zbigniew ^a   Demkow, Marcin ^a   Michałek, Piotr ^a   Ksiȩzycka Majczyńska, Ewa ^a   Chojnowska, Stefania Lidia ^a   Hryniewiecki, Tomasz ^a   Kuśmierski, Krzysztof ^a   Juraszyński, Zbigniew ^a   Czerwińska, Katarzyna ^a   Sitkowska Rysiak, Ewa ^a   Stȩpińska, Janina ^a   Ruzyłło, Witold ^a   Witkowski, Adam ^a  

^a INSTITUTE OF CARDIOLOGY   (Poland)

Author keywords

Aortic stenosis; Contrast; Nephropathy; Trans catheter aortic valve implantation

Indexed keywords

ACETYLCYSTEINE; CONTRAST MEDIUM; IODIXANOL; IOMEPROL;

AGED; AORTA VALVE; AORTA VALVE REPLACEMENT; AORTA VALVE STENOSIS; ARTICLE; CLINICAL ARTICLE; COMORBIDITY; CONTRAST INDUCED NEPHROPATHY; CREATININE BLOOD LEVEL; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FUNCTION; MALE;

EID: 79955425554     PISSN: 00229032     EISSN: 00229032     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Iung B, Baron G, Butchart EG et al. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on valvular heart disease in Europe: The Euro Heart Survey on valvular disease. Eur Heart J, 2003; 24: 1231-1243. (Pubitemid 36834640)
2. Vahanian A, Baumgartner H, Bax J et al. Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J, 2007; 28: 230-68. (Pubitemid 46276943)
3. Vahanian A, Otto CM. Risk stratification of patients with aortic stenosis. Eur Heart J, 2010; 31: 416-423.
4. Webb JG, Pasupati S, Humphries K et al. Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis. Circulation, 2007; 116: 755-763. (Pubitemid 47255993)
5. Rodés-Cabau J, Webb JG, Cheung A et al. Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk. J Am Coll Cardiol, 2010; 55: 1080-1090.
6. Vahanian A, Alfieri OR, Al-Attar N et al. Transcatheter valve implantation for patients with aortic stenosis: a position statement from the European Association of Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur J Cardiothorac Surg, 2008; 34: 1-8.
7. Ye J, Cheung A, Lichtenstein SV et al. Six-month outcome of transapical transcatheter aortic valve implantation in the initial seven patients. Eur J Cardiothorac Surg, 2007; 31: 16-21. (Pubitemid 44880770)
8. Ye J, Cheung A, Lichtenstein SV et al. Transapical transcatheter aortic valve implantation: follow-up to 3 years. Thorac Cardiovasc Surg, 2010; 139: 1107-1113.
9. Cribier A, Eltchaninoff H, Bash A et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation, 2002; 106: 3006-3008. (Pubitemid 35440280)
10. Wilczek K, Chodór P, Zembala M. Komu przezcewnikowo wszczepiać zastawkȩ aortalna̧? Czas na leczenie także w Polsce. Kardiol Pol, 2008; 66: 1148-1151.
11. Przybylski R, Wilczek, Zembala M et al. Przezkoniuszkowe, małoinwazyjne wszczepienie zastawek aortalnych u dwóch kobiet z ciȩżka̧ objawowa̧ stenoza̧ aortalna̧ i współistnieja̧cymi obcia̧żeniami szansa̧ dla najtrudniejszych chorych. Pierwsze polskie pomyślne doświadczenia. Kardiol Pol, 2008; 66: 1350-1356.
12. Wilczek K, Chodór P, Laborde J-C et al. Przezskórne, przezudowe implantacje zastawki aortalnej CoreValve® u chorych bardzo wysokiego ryzyka operacyjnego - nowe polskie doświadczenia. Kardiol Pol, 2009; 67: 1162-1165.
13. Zembala M, Wilczek K, Przybylski R et al. Raport POL-TAVI FIRST z zastosowania przezcewnikowej implantacji zastawki aortalnej typu Edwards-Sapien u pierwszych w Polsce 19 chorych z grupy bardzo dużego ryzyka, z ciȩżka̧ stenoza̧ aortalna̧ i chorobami obcia̧żaja̧cymi rokowanie. Kardiol Pol, 2009; 67: 936-940.
14. Leon MB , Smith CR , Mack M et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med, 2010; 363: 1597-1607.
15. Webb JG, Chandavimol M, Thompson CR et al. Percutaneous aortic valve implantation retrograde from the femoral artery. Circulation, 2006; 113: 842-850.
16. Ye J, Cheung A, Lichtenstein SV et al. Transapical aortic valve implantation in humans. J Thorac Cardiovasc Surg, 2006; 131: 1194-1196.
17. Mc Cullough PA. Contrast-induced acute kidney injury. J Am Coll Cardiol, 2008; 51: 1419-1428. (Pubitemid 351471786)
18. Cronin RE. Contrast-induced nephropathy: pathogenesis and prevention. Pediatr Nephrol, 2010; 25: 191-204.
19. Weisbord SD, Mor MK, Resnick AL. Prevention, incidence and outcomes of contrast-induced acute kidney injury. Arch Intern Med, 2008; 168: 1325-1332. (Pubitemid 351930840)
20. Tepel M, van der Giet M, Schwarzfeld C et al. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med, 2000; 343: 180-184. (Pubitemid 30489215)
21. Reddan D, Laville M, Garovic VD. Contrast-induced nephropathy and its prevention: what do we really know from evidence - based findings? J Nephrol, 2009; 22: 333-351.
22. Bagur R, Webb JG, Nietlispach F et al. Acute kidney injury following transcatheter aortic valve implantation: predictive factors, prognostic value, and comparison with surgical aortic valve replacement. Eur Heart J, 2010; 31: 865-874.
23. Chronic kidney disease as a public health problem. Clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Part 3. Am J Kidney Dis, 2002; 39: S37-S46.
24. Aregger F, Wenaweser P, Hellige GJ et al. Risk of acute kidney injury in patients with severe aortic valve stenosis undergoing transcatheter valve replacement. Nephrol Dial Transplant, 2009; 24: 2175-2179.
25. Sidhu RB, Brown JR, Robb JF. Interaction of gender and age on post cardiac catheterization contrast-induced acute kidney injury. Am J Cardiol, 2008; 102: 1482-1486.
26. Strauch JT, Scherner MP, Haldenwang PL et al. Minimally invasive transapical aortic valve implantation and the risk of acute kidney injury. Ann Thorac Surg, 2010; 89: 465-470.